← Back
Data updated: Mar 10, 2026
HISAMITSU
Pharmaceuticals
HISAMITSU is a pharmaceutical company with 2 FDA-approved products.
2008
Since
2
Drugs
-
Trials
2
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...